Abattis Bioceuticals Corp. (ATT.TO) Thursday said it has completed the acquisition of 49% stake in CannaNUMUS Blockchain Inc.
The company also announced that CannaNUMUS has achieved the first milestone under the Investment Agreement by entering into an agreement with Active Health Products Ltd.
"We are excited to see such immediate progress on our investment in CannaNUMUS," stated Rob Abenante, President and CEO of Abattis. "We believe this is just beginning of many more lucrative agreements and synergies for CannaNUMUS with LPs and also Licensed Dealers," added Abenante.
Abattis believes that its investment in CannaNUMUS will appreciate significantly in value as CannaNUMUS gets closer to an ICO and signs agreements with Licensed Producers and late stage LP applicants.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org